Daunorubicin-13C,d3 - HY-W654130
Catalog #
HY-W654130
2.025,00 €
Daunorubicin-13C,d3 is 13C and deuterium labeled Daunorubicin. Daunorubicin (Daunomycin) is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin inhibits DNA and RNA synthesis. Daunorubicin is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin is also an anthracycline antibiotic. Daunorubicin can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor[1][4][5].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-W654130/Daunorubicin-13C-d3-DataSheet-MedChemExpress.pdf |
|---|---|
| Quantity | 250ug |
| Shipping | Room temperature |
| Application | Cancer-programmed cell death |
| Alternative Names | Daunomycin-13C,d3; RP 13057-13C,d3; Rubidomycin-13C,d3 |
| MWT | 531.53 |
| Clinical Information | No Development Reported |
| Target | ADC Payload;Antibiotic;Apoptosis;Autophagy;Bacterial;DNA/RNA Synthesis;Isotope-Labeled Compounds;Topoisomerase |
| Application: | Cancer-programmed cell death |
|---|